Metraipolis › archive › dc_2c7cd4bf04ca

Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicity in Melanoma: Current Evidence and Practical Clinical Management — Europe PMC PMID:42795007

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42795007
DOI: 10.3390/cancers18183041
License (as archived): solo-consultazione
Archived: 2026-10-08T03:48:59.172Z
SHA-256 of the archived text: 42366fc5d36200a4c3c0da53ea8de8be36fd5cfb068c8f41b12439ce9f578aa8
Stable URL of this page: https://metraipolis.com/documento/dc_2c7cd4bf04ca

How to cite

Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicity in Melanoma: Current Evidence and Practical Clinical Management — Europe PMC PMID:42795007 — Europe PMC (en), https://europepmc.org/article/MED/42795007 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2c7cd4bf04ca (Metraipolis archive dc_2c7cd4bf04ca, sha256 42366fc5d36200a4c3c0da53ea8de8be36fd5cfb068c8f41b12439ce9f578aa8)

BibTeX

@misc{dc2c7cd4bf04ca,
  title = {Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicity in Melanoma: Current Evidence and Practical Clinical Management — Europe PMC PMID:42795007},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42795007},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2c7cd4bf04ca; sha256 42366fc5d36200a4c3c0da53ea8de8be36fd5cfb068c8f41b12439ce9f578aa8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42795007. Agents can read the archived copy with the MCP tool read_document.